Incident Atrial Fibrillation and Risk of Death in Adults With Chronic Kidney Disease
暂无分享,去创建一个
A. Go | N. Bansal | Chi-yuan Hsu | D. Fan | J. Ordonez | C. Hsu | Dongjie Fan
[1] T. Dawber,et al. The Framingham Study , 2014 .
[2] Talicia A Tarver. HEART DISEASE AND STROKE STATISTICS–2014 UPDATE: A REPORT FROM THE AMERICAN HEART ASSOCIATION , 2014 .
[3] S. Yusuf,et al. Blockade of the renin-angiotensin-aldosterone system (RAAS) for primary prevention of non-valvular atrial fibrillation: a systematic review and meta analysis of randomized controlled trials. , 2013, International journal of cardiology.
[4] G. Marcus,et al. Incident Atrial Fibrillation and Risk of End-Stage Renal Disease in Adults With Chronic Kidney Disease , 2013, Circulation.
[5] M. Joffe,et al. Association between albuminuria, kidney function, and inflammatory biomarker profile in CKD in CRIC. , 2012, Clinical journal of the American Society of Nephrology : CJASN.
[6] J. Spertus,et al. The prevalence of and factors associated with chronic atrial fibrillation in Medicare/Medicaid-eligible dialysis patients. , 2012, Kidney international.
[7] R. Asinger,et al. Warfarin in atrial fibrillation patients with moderate chronic kidney disease. , 2011, Clinical journal of the American Society of Nephrology : CJASN.
[8] S. Baldus,et al. Inflammatory pathways underlying atrial fibrillation. , 2011, Trends in molecular medicine.
[9] Bertram L Kasiske,et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. , 2011, Kidney international.
[10] Josef Coresh,et al. Chronic Kidney Disease Is Associated With the Incidence of Atrial Fibrillation: The Atherosclerosis Risk in Communities (ARIC) Study , 2011, Circulation.
[11] Kortaro Tanaka,et al. Chronic kidney disease and CHADS(2) score independently predict cardiovascular events and mortality in patients with nonvalvular atrial fibrillation. , 2011, The American journal of cardiology.
[12] E. Benjamin,et al. Inflammation, kidney function and albuminuria in the Framingham Offspring cohort. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[13] Elsayed Z Soliman,et al. Association of Chronic Kidney Disease With Atrial Fibrillation Among Adults in the United States: REasons for Geographic and Racial Differences in Stroke (REGARDS) Study , 2011, Circulation. Arrhythmia and electrophysiology.
[14] W. Winkelmayer,et al. The increasing prevalence of atrial fibrillation among hemodialysis patients. , 2011, Journal of the American Society of Nephrology : JASN.
[15] S. Dudley,et al. Atrial fibrillation: the emerging role of inflammation and oxidative stress. , 2010, Cardiovascular & hematological disorders drug targets.
[16] C. Herzog,et al. Abstract 18013: Impact of Chronic Kidney Disease on Risk of Incident Atrial Fibrillation and Subsequent Survival in Medicare Patients , 2010 .
[17] Satoko Nakamura,et al. Chronic kidney disease as an independent risk factor for new-onset atrial fibrillation in hypertensive patients , 2010, Journal of hypertension.
[18] P. Kerr,et al. Atrial fibrillation in hemodialysis patients: clinical features and associations with anticoagulant therapy. , 2010, Kidney international.
[19] A. Go,et al. Chronic kidney disease and prevalent atrial fibrillation: the Chronic Renal Insufficiency Cohort (CRIC). , 2010, American heart journal.
[20] E. Lerma,et al. Prevalence of atrial fibrillation and its predictors in nondialysis patients with chronic kidney disease. , 2010, Clinical journal of the American Society of Nephrology : CJASN.
[21] A. Folsom,et al. Incidence of atrial fibrillation in whites and African-Americans: the Atherosclerosis Risk in Communities (ARIC) study. , 2009, American heart journal.
[22] C. Schmid,et al. A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.
[23] C. McCulloch,et al. Risk factors for end-stage renal disease: 25-year follow-up. , 2009, Archives of internal medicine.
[24] S. Iravanian,et al. The renin-angiotensin-aldosterone system (RAAS) and cardiac arrhythmias. , 2008, Heart rhythm.
[25] Maria Grazia Valsecchi,et al. Atrial fibrillation and morbidity and mortality in a cohort of long-term hemodialysis patients. , 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[26] Melissa M. Parker,et al. Glycemic response to newly initiated diabetes therapies. , 2007, The American journal of managed care.
[27] A. Go,et al. Statin therapy and risks for death and hospitalization in chronic heart failure. , 2006, JAMA.
[28] E. Maltezos,et al. Relation of C-reactive protein to the first onset and the recurrence rate in lone atrial fibrillation. , 2006, The American journal of cardiology.
[29] J. Langberg,et al. Atrial Fibrillation Increases Production of Superoxide by the Left Atrium and Left Atrial Appendage: Role of the NADPH and Xanthine Oxidases , 2005, Circulation.
[30] G. Beck,et al. C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease. , 2005, Kidney international.
[31] Charles E McCulloch,et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. , 2004, The New England journal of medicine.
[32] Yuchiao Chang,et al. Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice? , 2003, JAMA.
[33] B. Psaty,et al. Elevations of Inflammatory and Procoagulant Biomarkers in Elderly Persons With Renal Insufficiency , 2003, Circulation.
[34] Cynthia A. Carnes,et al. C-Reactive Protein Elevation in Patients With Atrial Arrhythmias: Inflammatory Mechanisms and Persistence of Atrial Fibrillation , 2001, Circulation.
[35] D. Singer,et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. , 2001, JAMA.
[36] J. Selby,et al. Evaluating hypertension control in a managed care setting. , 1999, Archives of internal medicine.
[37] M A Waclawiw,et al. Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. Studies of Left Ventricular Dysfunction. , 1998, Journal of the American College of Cardiology.
[38] D. Levy,et al. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. , 1994, JAMA.
[39] P. Wolf,et al. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. , 1991, Stroke.
[40] P. Wolf,et al. Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study. , 1987, Archives of internal medicine.
[41] A. Belanger,et al. The Framingham study. , 1976, British medical journal.